Again, this heterogeneity likely originates from early events in the tumour cells that impact on the stromal cells (for instance a SMAD4 mutation [162]), but it is also possible that stochastic or epigenetic events in the stromal gene expression pattern drive this. Here, SMAD4 is linked to neoplasm.